You are currently viewing a new version of our website. To view the old version click .
Biomedicines
  • Correction
  • Open Access

25 October 2024

Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022, 10, 985

,
,
,
,
,
,
,
,
and
1
Laboratory of Drug Delivery Technology, Department of Drug and Health Sciences, University of Catania, 95125 Catania, Italy
2
Department of Biomedical and Biotechnological Sciences, Section of Pharmacology, University of Catania, 95123 Catania, Italy
3
Dipartimento di Fisica e Astronomia “Ettore Majorana”, Università di Catania, Via Santa Sofia 64, 95123 Catania, Italy
4
CNR-IMM UoS Catania, Istituto per La Microelettronica e Microsistemi, Via Santa Sofia 64, 95123 Catania, Italy
This article belongs to the Special Issue State of the Art: Neurodegenerative Diseases in Italy

Error in Figure

Figure 5 in the original publication [] was selected by mistake instead of the right one. The subfigures of panel A (a–c′; f′) and panel B (d–f′; g–i′) have now been replaced with the correct version, as the one originally submitted with the manuscript was uploaded by mistake. The corrected Figure 5 now appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 5. Comparison of polymeric or lipidic nanoparticles complexed with anti-TRAIL in the hippocampus of 3xTg-AD mice after intranasal administration. Representative immunofluorescence microscopy images showing the localization of the anti-TRAIL monoclonal antibody in the hippocampal sections from WT (A) or 3×Tg-AD (B) mice intranasally administered for 24 h with the anti-TRAIL monoclonal antibody, empty, or anti-TRAIL-loaded NANO-A, NANO-B nanoparticles. The fluorescence signal was detected by using a fluorescent secondary anti-rat IgG. The insets represent the respective areas magnified. (C) The densitometric count of fluorescence was performed with the aid of ImageJ software (available online: https://imagej.nih.gov/ij/ (accessed on 12 January 2022)) and represented as integrated density (% of control). Data are expressed as the mean ± SD. One-way ANOVA followed by Fisher’s LSD test was used for statistical analysis. * p < 0.05. (a–o scale bar = 50 µm; c’, f’, i’, l’, o’ scale bar = 10 µm).

Reference

  1. Musumeci, T.; Di Benedetto, G.; Carbone, C.; Bonaccorso, A.; Amato, G.; Lo Faro, M.J.; Burgaletto, C.; Puglisi, G.; Bernardini, R.; Cantarella, G. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer’s Disease. Biomedicines 2022, 10, 985. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.